TY - JOUR
T1 - Retention in care within 1 year of initial HIV care visit in a multisite US cohort
T2 - Who's in and who's out?
AU - Tedaldi, Ellen M.
AU - Richardson, James T.
AU - Debes, Rachel
AU - Young, Benjamin
AU - Chmiel, Joan S.
AU - Durham, Marcus D.
AU - Brooks, John T.
AU - Buchacz, Kate
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Centers for Disease Control and Prevention (contract nos. 200-2001-00133, 200-2006-18797, and 200-2011-41872). Ellen Tedaldi received a research grant from Gilead Sciences. Ben Young is a speaker for Bristol-Myers Squibb, Gilead, Glaxo-Smith Kline, Monogram Sciences, ViiV Health Care, and Merck and has received research support from Glaxo-Smith Kline, Gilead Sciences, ViiV Health Care, BMS, and Merck. Ken Lichtenstein is on the advisory board for Gilead, Boeringer-Ingelheim and is a researcher for Gilead and Abbievie.
PY - 2014
Y1 - 2014
N2 - Biannual attendance at medical visits is an established measure of retention in HIV care. We examined factors associated with attending at least 2 clinic visits at least 90 days apart among HIV-infected, antiretroviral therapy (ART)-naive HIV Outpatient Study participants entering care during 2000 to 2011. Of 1441 patients, 85% were retained in care during the first year of observation. Starting ART during the year was the strongest correlate of retention (adjusted odds ratio [aOR] 6.4, 95% confidence interval [CI] 4.4-9.4). After adjusting for starting ART, publicly insured patients (aOR 0.6, 95% CI 0.4-1.0), and patients with baseline CD4 counts <200 cells/mm3 (aOR 0.5, 95% CI 0.3-0.9) or missing CD4 counts (aOR 0.3, 95% CI 0.2-0.6) were less likely to be retained in care. Although most patients had recommended biannual care visits, some ART-naive individuals may require additional interventions to remain in care. Promptly initiating ART may facilitate engagement in care.
AB - Biannual attendance at medical visits is an established measure of retention in HIV care. We examined factors associated with attending at least 2 clinic visits at least 90 days apart among HIV-infected, antiretroviral therapy (ART)-naive HIV Outpatient Study participants entering care during 2000 to 2011. Of 1441 patients, 85% were retained in care during the first year of observation. Starting ART during the year was the strongest correlate of retention (adjusted odds ratio [aOR] 6.4, 95% confidence interval [CI] 4.4-9.4). After adjusting for starting ART, publicly insured patients (aOR 0.6, 95% CI 0.4-1.0), and patients with baseline CD4 counts <200 cells/mm3 (aOR 0.5, 95% CI 0.3-0.9) or missing CD4 counts (aOR 0.3, 95% CI 0.2-0.6) were less likely to be retained in care. Although most patients had recommended biannual care visits, some ART-naive individuals may require additional interventions to remain in care. Promptly initiating ART may facilitate engagement in care.
KW - HIV infection
KW - antiretroviral adherence
KW - retention
UR - http://www.scopus.com/inward/record.url?scp=84900341587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900341587&partnerID=8YFLogxK
U2 - 10.1177/2325957413514631
DO - 10.1177/2325957413514631
M3 - Article
C2 - 24493009
AN - SCOPUS:84900341587
SN - 2325-9574
VL - 13
SP - 232
EP - 241
JO - Journal of the International Association of Providers of AIDS Care
JF - Journal of the International Association of Providers of AIDS Care
IS - 3
ER -
